Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FDAOncology: #FDAOncology comment: Approvals in 2018: a histology-agnostic new molecular entity, novel end points and real-time… https://t.co/t23kWvxsHg

We're putting out data soon on our overall footprint when it comes to oversight of generic drug manufacturing; but inspections are up, so are enforcement actions related to inspectional activities, reflecting the expanding scope of our overall supervision https://t.co/gXQMmtrsPW

New #FDA final guidance on “least burdensome” concept of assuring safety and effectiveness of medical devices outlines our focus on policies that apply modern, science-based approaches to closely evaluating safety while advancing beneficial innovations https://t.co/i0Up3ursSI https://t.co/iH718aeagc

RT @PartnersforGood: RT @us_fda: .@SGottliebFDA & @Surgeon_General sat down w/ @Medscape to discuss risks of e-cig use in kids & how to… https://t.co/dC1AfhpSaW

USP will develop and update quality standards to support #FDA’s Drug Competition Action Plan. Manufacturers can rely on the USP quality standards to help accelerate availability of generic versions of off-patent medicines. https://t.co/juxnJctql4

FDA SAFETY ALERT: Yesterday #FDA communicated to healthcare providers concerning interim results from PAS study that shows increased death rates for a heart pump used temporarily to stabilize heart function in severely ill patients. https://t.co/U6AyP1e5r5

#FDA announced an Advisory Committee meeting scheduled for March 6, 2019 that will discuss and make recommendations on the selection of flu virus strains to be included in the flu vaccine for the 2019‐2020 flu season. https://t.co/MOGwxMxxQt https://t.co/wOB8dqrx2x

One of the most effective and safest ways to prevent influenza for you and your family is to get the #flu vaccine every year. #FDA and @CDCgov recommend that most individuals 6 months of age and older get the flu vaccine. It’s not too late to get vaccinated for this flu season.

#FDA works year-round to ensure vaccines are safe, effective and manufactured to high quality standards. This includes evaluating and potentially adjusting the composition of the flu vaccine every year so that it matches the strains expected to be in circulation. https://t.co/TFyBWwRgMi

#FDA is holding a workshop to provide an overview of current regulatory science initiatives for generic drugs and opportunity for input on these initiatives which will be taken into account when developing upcoming regulatory science initiatives. https://t.co/FQBlhWVMDL https://t.co/59iJEDy1Dk

RT @tmprowell: Registration open for free (online or in person) FDA-NBTS Public Workshop: Product Dev for Central Nervous System M… https://t.co/Z1E2yTqvnu

RT @FDA_Drug_Info: New Drug Trials Snapshot Summary Report summarizes CDER’s 2018 Drug Trials Snapshot program, highlighting the 59 no… https://t.co/MAPD3ZNuo1

RT @tmprowell: In 2018, there were 5,157 pts in #oncology trials that resulted in #FDA approval of 17 entirely new #cancer drugs. A snapsho… QT @SGottliebFDA: Our new 2018 Drug Trials Snapshots Summary Report shows important details about 43,966 participants in clinical tri… https://t.co/UgUV1fct1F)

Today’s action is one of the many steps that we’re taking to help advance the development of new treatments for opioid use disorder. Read more about #FDA's work to forcefully address the opioid crisis: https://t.co/W6Ig8gtJbI

Today #FDA finalized a new policy to encourage widespread innovation and development of new buprenorphine treatments for opioid use disorder as part of efforts to support more widespread adoption of medication-assisted treatment: https://t.co/eCS8rC9lfD https://t.co/dEELe9l7fU

THREAD: Today #FDA provided updated numbers of medical device reports received regarding breast implant associated anaplastic large cell lymphoma, BIA-ALCL, a known risk with these breast implants https://t.co/Ds4KHzIuxN

RT @WHO: #Measles is one of the most contagious diseases on the planet. When people are unvaccinated, it can very quickly sp… https://t.co/cyfvsxJs7D

RT @FDATobacco: FDA developed two new youth vaping prevention posters about the potential health consequences of youth e-cigarette… https://t.co/26g4VdfG6o

Through this program, we believe we can improve the overall security of the supply chain, prevent illegitimate products from entering, better detect illegitimate products and respond more quickly when they’re discovered.

In our continuing efforts to ensure safe and high-quality drug products for U.S. consumers, today we’re announcing a new track-and-trace pilot program for industry as an opportunity to test new technologies for ensuring accountability in the supply chain. https://t.co/IF6YdnsRWx

RT @FDAOncology: #FDAOncology comment: Approvals in 2018: a histology-agnostic new molecular entity, novel end points and real-time… https://t.co/t23kWvxsHg

We're putting out data soon on our overall footprint when it comes to oversight of generic drug manufacturing; but inspections are up, so are enforcement actions related to inspectional activities, reflecting the expanding scope of our overall supervision https://t.co/gXQMmtrsPW

New #FDA final guidance on “least burdensome” concept of assuring safety and effectiveness of medical devices outlines our focus on policies that apply modern, science-based approaches to closely evaluating safety while advancing beneficial innovations https://t.co/i0Up3ursSI https://t.co/iH718aeagc

RT @PartnersforGood: RT @us_fda: .@SGottliebFDA & @Surgeon_General sat down w/ @Medscape to discuss risks of e-cig use in kids & how to… https://t.co/dC1AfhpSaW

USP will develop and update quality standards to support #FDA’s Drug Competition Action Plan. Manufacturers can rely on the USP quality standards to help accelerate availability of generic versions of off-patent medicines. https://t.co/juxnJctql4

FDA SAFETY ALERT: Yesterday #FDA communicated to healthcare providers concerning interim results from PAS study that shows increased death rates for a heart pump used temporarily to stabilize heart function in severely ill patients. https://t.co/U6AyP1e5r5

#FDA announced an Advisory Committee meeting scheduled for March 6, 2019 that will discuss and make recommendations on the selection of flu virus strains to be included in the flu vaccine for the 2019‐2020 flu season. https://t.co/MOGwxMxxQt https://t.co/wOB8dqrx2x

One of the most effective and safest ways to prevent influenza for you and your family is to get the #flu vaccine every year. #FDA and @CDCgov recommend that most individuals 6 months of age and older get the flu vaccine. It’s not too late to get vaccinated for this flu season.

#FDA works year-round to ensure vaccines are safe, effective and manufactured to high quality standards. This includes evaluating and potentially adjusting the composition of the flu vaccine every year so that it matches the strains expected to be in circulation. https://t.co/TFyBWwRgMi

#FDA is holding a workshop to provide an overview of current regulatory science initiatives for generic drugs and opportunity for input on these initiatives which will be taken into account when developing upcoming regulatory science initiatives. https://t.co/FQBlhWVMDL https://t.co/59iJEDy1Dk

RT @tmprowell: Registration open for free (online or in person) FDA-NBTS Public Workshop: Product Dev for Central Nervous System M… https://t.co/Z1E2yTqvnu

RT @FDA_Drug_Info: New Drug Trials Snapshot Summary Report summarizes CDER’s 2018 Drug Trials Snapshot program, highlighting the 59 no… https://t.co/MAPD3ZNuo1

RT @tmprowell: In 2018, there were 5,157 pts in #oncology trials that resulted in #FDA approval of 17 entirely new #cancer drugs. A snapsho… QT @SGottliebFDA: Our new 2018 Drug Trials Snapshots Summary Report shows important details about 43,966 participants in clinical tri… https://t.co/UgUV1fct1F)

Today’s action is one of the many steps that we’re taking to help advance the development of new treatments for opioid use disorder. Read more about #FDA's work to forcefully address the opioid crisis: https://t.co/W6Ig8gtJbI

Today #FDA finalized a new policy to encourage widespread innovation and development of new buprenorphine treatments for opioid use disorder as part of efforts to support more widespread adoption of medication-assisted treatment: https://t.co/eCS8rC9lfD https://t.co/dEELe9l7fU

THREAD: Today #FDA provided updated numbers of medical device reports received regarding breast implant associated anaplastic large cell lymphoma, BIA-ALCL, a known risk with these breast implants https://t.co/Ds4KHzIuxN

RT @WHO: #Measles is one of the most contagious diseases on the planet. When people are unvaccinated, it can very quickly sp… https://t.co/cyfvsxJs7D

RT @FDATobacco: FDA developed two new youth vaping prevention posters about the potential health consequences of youth e-cigarette… https://t.co/26g4VdfG6o

Through this program, we believe we can improve the overall security of the supply chain, prevent illegitimate products from entering, better detect illegitimate products and respond more quickly when they’re discovered.

In our continuing efforts to ensure safe and high-quality drug products for U.S. consumers, today we’re announcing a new track-and-trace pilot program for industry as an opportunity to test new technologies for ensuring accountability in the supply chain. https://t.co/IF6YdnsRWx